No Data
GoodRx to Participate in Upcoming Investor Conferences
RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
GoodRx Holdings Chief Accounting Officer Romin Nabiey Sells 55% Of Holding
RBC Capital Keeps Their Buy Rating on GoodRx Holdings (GDRX)
Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc ...
GoodRx Holdings: A Hold Rating Amid Mixed Performance and Market Challenges
Tan Chin Seng klang : must buy more apples and Nvidia